SCHEMBL23925781

SCHEMBL23925781

CCc1c(-c2ccccc2)oc(=O)c(O)c1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.39
KMT2A Q03164 8/20 0.39
KDM4E B2RXH2 5/20 0.39
CYP3A4 P08684 4/20 0.39
ALOX15 P16050 3/20 0.39
LMNA P02545 2/20 0.39
TP53 P04637 2/20 0.39
MAPK1 P28482 2/20 0.39
CA12 O43570 2/20 0.39
ABCB1 P08183 2/20 0.39
CYP1B1 Q16678 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CALM1 P0DP23 1/20 0.39
AR P10275 1/20 0.39
PKM P14618 1/20 0.39
CA9 Q16790 1/20 0.39
POLB P06746 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23925819 0.83 KDM4E (0.40) MEN1KMT2AKDM4ECYP3A4ALOX15
SCHEMBL23925906 0.80 CYP3A4 (0.46) MEN1KMT2AKDM4ECYP3A4ALOX15
SCHEMBL23940763 0.79 KDM4E (0.37) MEN1KMT2AKDM4ECYP3A4ALOX15
SCHEMBL25144838 0.78 ELANE (0.44) MEN1KMT2AKDM4ECYP3A4ALOX15
SCHEMBL23925729 0.78 BCL2 (0.45) MEN1KMT2AKDM4ECYP3A4ALOX15
SCHEMBL13545615 0.73 ABCG2 (0.41) MEN1KMT2AKDM4ECYP3A4ALOX15
SCHEMBL25144976 0.71 ELANE (0.44) KDM4ECYP3A4LMNAMAPK1PKM
SCHEMBL23940764 0.70 HPGD (0.42) MEN1KMT2AKDM4ECYP3A4ALOX15
SCHEMBL10869318 0.70 MEN1 (0.50) MEN1KMT2AKDM4ECYP3A4ALOX15
SCHEMBL23925826 0.68 MCL1 (0.49) MEN1KMT2AKDM4ECYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS CYP2B6, TYR, CYP2D6 MEN1 3142/4885KMT2A 2212/4885KDM4E 1082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.